1. Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1+ CD8+ T cells in HCC via blocking VEGFR2. Issue 4 (20th January 2023) Authors: Mei, Zhibin; Gao, Xingxing; Pan, Caixu; Wu, Qinchuan; Wang, Shuai; Qian, Junjie; Xu, Zhentian; Xu, Kangdi; Zhou, Lin; Zhen, Shushen Journal: Cancer science Issue: Volume 114:Issue 4(2023) Page Start: 1284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗